瑞朗医药 (835600.OC)

+ 收藏

利润表(瑞朗医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 612,755,437.021,279,683,325.51624,832,700.481,217,797,349.67567,959,195.21
 营业收入(元) 612,755,437.021,279,683,325.51624,832,700.481,217,797,349.67567,959,195.21
二、营业总成本(元) 607,559,869.001,266,527,931.08619,666,366.481,200,334,932.46564,200,183.58
 营业成本(元) 571,448,799.321,188,285,688.54580,158,267.821,135,053,003.57530,305,989.14
 营业税金及附加(元) 918,462.012,709,428.401,683,994.33713,856.21827,507.18
 销售费用(元) 18,628,415.3241,329,986.8520,939,213.8634,648,573.9618,565,485.12
 管理费用(元) 6,260,653.1511,750,665.216,591,082.2411,364,709.265,810,059.19
 财务费用(元) 10,303,539.2022,452,162.0810,293,808.2318,554,789.468,691,142.95
  其中:利息费用(元) 10,123,863.9221,584,176.0810,107,572.3716,981,033.817,678,859.70
  其中:利息收入(元) 211,768.95502,782.56278,630.03393,034.77194,796.11
三、其他经营收益
 加:投资收益(元) -196,271.47-126,158.26-256,332.19-18,026.61-
 资产处置收益(元) -90,744.3090,744.30--
 资产减值损失(元) -101,817.66-115,238.67-98,577.01-119,324.39-90,736.67
 信用减值损失(元) 62,373.42-94,084.08179,575.46-1,037,481.07164,809.10
 其他收益(元) 176,585.19285,459.18136,583.061,458,466.55434,806.66
四、营业利润(元) 5,136,437.5013,196,116.905,218,327.6217,746,051.694,267,890.72
 加:营业外收入(元) 25,306.97151,714.5385,412.32369,535.9819,376.54
 减:营业外支出(元) 68,772.37262,405.33279,270.84225,414.25126,413.57
五、利润总额(元) 5,092,972.1013,085,426.105,024,469.1017,890,173.424,160,853.69
 减:所得税费用(元) 1,462,856.193,369,222.551,793,741.063,345,405.05872,546.50
六、净利润(元) 3,630,115.919,716,203.553,230,728.0414,544,768.373,288,307.19
(一)按经营持续性分类
  持续经营净利润(元) 3,630,115.919,716,203.553,230,728.0414,544,768.373,288,307.19
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 3,630,115.919,716,203.553,230,728.0414,544,768.373,288,307.19
 扣除非经常性损益后的净利润(元) 3,778,062.599,800,883.913,205,626.4113,342,827.163,042,479.97
七、每股收益
 一、基本每股收益(元) 0.040.110.040.160.04
 二、稀释每股收益(元) 0.040.110.040.160.04
九、综合收益总额(元) 3,630,115.919,716,203.553,230,728.0414,544,768.373,288,307.19
 归属于母公司所有者的综合收益总额(元) 3,630,115.919,716,203.553,230,728.0414,544,768.373,288,307.19
公告日期 2024-08-272024-04-192023-08-252023-04-262022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院